The immunoregulatory cytokine IL-10 modulates the function of diverse immune and non-immune cells. Here we examine the chromatin structural changes associated with IL10 gene transcription by naïve and differentiated murine T cells. Naïve T cells lack DNase I hypersensitive (HS) sites in the vicinity of the IL10 gene, whereas differentiated T cells display a strong 3' constitutive HS site as well as several inducible sites. The majority of HS sites map to regions that are strongly conserved in sequence between mouse and human genomes. In committed Th1 cells, the mechanism of IL10 gene silencing is associated with the development of repressive histone modifications near the IL10 promoter and near intronic hypersensitive regions of the IL10 gene. Our results constitute the first report of chromatin structural differences within the IL10 gene in differentiated Th1 and Th2 cells, and emphasise the surprising diversity of mechanisms used to regulate cytokine gene expression at the chromatin level.
INTRODUCTION
IL-10 is an important regulatory cytokine with an overall immunosuppressive effect on the immune response. It is produced by many cell types, including T cells, B cells, monocytes, macrophages and dendritic cells. IL-10 makes a positive contribution to the growth and differentiation of B cells, mast cells, granulocytes, dendritic cells, keratinocytes and endothelial cells, but inhibits a broad spectrum of functions of activated macrophages and monocytes, including nitric oxide production, expression of MHC proteins, and expression of the costimulatory receptors CD80 and CD86 [see (1) for a review]. IL-10 inhibits NF-kB, a transcription factor involved in production of inflammatory cytokines (e.g. IL-1b, IL-6, IL-8, TNF-a), while stimulating production of cytokine inhibitors (e.g. IL-1 receptor antagonist and soluble TNF receptor) by monocytes/macrophages and neutrophils (2) . IL-10-deficient mice develop severe chronic enterocolitis (IBD), emphasising the protective role of this cytokine in inflammatory and autoimmune conditions. Paradoxically, however, IL-10 stimulates polyclonal B cell activation and thus has a pathogenic role in SLE; indeed, anti-IL-10 treatment ameliorates disease in a subset of human SLE patients.
At least two types of T helper (Th) cells, Th1 and Th2, have been distinguished based on their cytokine expression profiles (see (3) for review). Both are derived from a common precursor, naïve CD4 T cells that have not yet encountered antigen. When naïve T cells are stimulated through their T cell receptors in the presence of IL-12 and IFN-g, they differentiate to produce interferon (IFN)-g but not IL-4 or IL-10; in contrast when the same cells are stimulated in the presence of IL-4, they differentiate to show the converse pattern of cytokine production, IL-4 and IL-10 but not IFN-g. These mutually-exclusive patterns of cytokine production are predominantly observed in fully-committed Th1 and Th2 cells that have been exposed to differentiating stimuli ex vivo, under conditions where differentiation can be driven by high concentrations of TCR stimulation and polarizing cytokines. T cell clones made from these polarized cell populations are ideal for biochemical studies of gene expression, since they can be maintained by culture in the presence of the growth factor IL-2. In particular, Th1 and Th2 clones have been very useful in demonstrating that the IL4 and IFNg genes bear opposing chromatin modifications depending on the direction of polarization (4, 5) .
Th1 cells develop a strongly silenced chromatin configuration on the I L 4 gene but an "open" chromatin configuration characterized by increased DNase I hypersensitivity and histone acetylation on the IFNg gene; similarly, Th2 cells develop an active chromatin configuration and a complex pattern of DNase I hypersensitivity on the IL4 gene, while at the same time silencing the IFNg gene (6) . The expanded IL-10 family includes several viral members as well as the IL-10-related cytokines IL-19, IL-20, IL-22 (IL-TIF), IL-24 (MDA-7), and IL-26 (AK155). By sequence alignment, these cytokines display up to~30% amino acid sequence identity to IL-10 (up to~80% for the viral homologues (3). Based on the strong similarity between their crystal structures, IL-10 belongs to the same cytokine family as IFN-g (7), and the genes for the IL-10/ IFN-g family are clustered on two chromosomes, emphasising their relatively recent divergence during evolution. The genes encoding IL-22 and IL-26 are located in the close vicinity of the IFNg gene on chromosome 12q15, while the genes for IL-10, IL-19, IL-20 and IL-24 are located in a second cluster, flanked by the MAPKAP2 (mitogen-activated protein kinase-activated protein 2) and TOSO (a regulator of Fas-induced apoptosis) genes, which spans an~195kb region of human chromosome 1q31-32 syntenic to mouse chromosome 1E4 (Figure 1 ).
Although the immunoregulatory role of IL-10 has been extensively studied for decades, little information is available on the molecular mechanism of its transcriptional regulation, especially at the chromatin level. As a first approach to this question, we have examined the pattern of DNase I hypersensitivity in and around the IL10 gene in naïve and differentiated T cells. We show that while naïve T cells show no DNase I hypersensitive (HS) sites in the vicinity of the IL10 gene, differentiated T cells display a strong 3' constitutive HS site as well as several inducible sites. Essentially all the HS sites correspond to conserved non-coding regions (CNS) identified by sequence comparisons of mammalian genomes; but the pattern of inducible HS sites differs in Th1 and Th2 cells which silence and express the IL10 gene respectively. Committed Th1 cells develop repressive histone modifications at the IL10 promoter and at intronic hypersensitive regions of the IL10 gene, while committed Th2 cells develop an open chromatin configuration at the IL10 promoter and do not display the intronic hypersensitive sites. These data constitute the first report of chromatin structural changes that correlate with IL10 gene transcription.
RESULTS
The IL10 cytokine cluster Figure 1 shows the organisation of the IL10/ IL19/ IL20/ IL24 cytokine cluster on human chromosome 1q31-32, syntenic to mouse chromosome 1E4. The IL10 gene is located 35 kb from the MAPKAP2 gene in the human (25 kb in the mouse), and 62 kb from the IL19 gene (89 kb in the mouse). In this study we focus on a 22 kb region surrounding the IL10 gene, contained within two BamH I fragments of 6 and 16 kb (Figure 1 ).
Differential DNase I hypersensitivity of the IL10 gene in Th1 and Th2 cells
We compared the chromatin structure of the IL10 gene in Th1 and Th2 cells using two fullydifferentiated T cell clones, D5 and D10 (8, 9) . D5 cells, which belong to the Th1 subtype, have silenced the IL10 gene, and show no expression of IL10 mRNA regardless of whether or not they are stimulated. In contrast D10 cells, which belong to the Th2 subtype, basally express low levels of IL10 transcripts under resting conditions and rapidly induce IL10 mRNA and protein upon stimulation with either PMA and ionomycin or anti-CD3 (5) and data not shown). We used an exon 1 probe to examine the DNase I hypersensitivity pattern in the 5' region of the IL10 gene in these two cell types (Figure 2A ). Consistent with their basal expression of the IL10 gene, resting D10 cells showed a strong HS site at the proximal IL10 promoter; this site was not apparent in resting D5 cells which have silenced IL-10 gene expression ( Figure 2A ). We next repeated the experiment using primary Th1 and Th2 cells, which do not express or express high levels of IL10 mRNA and protein respectively ((5) and data not shown). Again, primary Th1 cells showed no evidence of DNase I hypersensitivity at the IL10 promoter while Th2 cells showed an obvious HS site ( Figure 2B ).
We used probes spanning exon 3 and exon 5 to monitor DNase I hypersensitivity patterns in the 16 kb Bam HI fragment containing the 3' region of the IL10 gene (Figure 3 ). Using the exon 3 probe and resting D5 T cells, we showed that these cells displayed a strong constitutive HS site (designated HS site III) located~5.5 kb from the intronic Bam HI site (Figures 3A, E; black arrows). Stimulation resulted in the appearance of strong inducible bands of 1 and 2.5 kb, corresponding to cleavage at inducible HS sites I and II (Figures 3A, 3E ; grey arrows). These bands were weakly induced by ionomycin stimulation alone ( Figure 3A , lanes 7-12), substantially more strongly induced upon stimulation with both PMA and ionomycin (lanes [13] [14] [15] [16] [17] [18] , and lost upon stimulation in the presence of CsA (lanes [19] [20] [21] [22] [23] . In addition, we also observed weak inducible bands of~7 kb and~8 kb corresponding to HS sites IV and V (Figures 3A, 3E ; grey arrows). A very similar pattern was observed when the same blot was rehybridised with the exon 5 probe (data not shown). A diagram interpreting these hypersensitivity patterns is shown in Figure 3E .
We repeated the DNase I hypersensitivity analysis using the D10 Th2 clone ( Figure 3B ). Although resting D10 cells displayed the constitutive HS site located~5.5 kb from the intronic Bam HI site ( Figure 3B ), they showed a far more limited pattern of inducible HS sites. Specifically, they did not show the inducible bands of 1 and 2.5 kb, corresponding to cleavage at inducible HS sites I and II, although they did display the inducible bands of~7 kb and~8 kb resulting from cleavage at HS sites IV and V ( Figure 3B , E).
We confirmed that primary T cells displayed a similar pattern of HS sites ( Figure 3C , D). Naïve precursor CD4 T cells showed no evidence of any HS sites on the IL10 gene, using either the exon 5 or the exon 1 probe (data not shown). However the patterns of DNase I hypersensitivity observed in primary differentiated Th1 and Th2 cells were similar to those observed in D5 and D10 clones respectively. Specifically, primary Th1 cells exhibited the intronic HS sites whereas primary Th2 cells did not ( Figure 3C, D) .
Together, these data show that Th1 and Th2 cells differ in their patterns of DNase I hypersensitivity on the IL10 gene. Curiously Th1 cells, which do not express the IL10 gene, show a more complex pattern of HS sites in the vicinity of the IL10 gene than do Th2 cells which strongly express the gene.
Silencing of the IL10 promoter in the D5 Th1 clone
The presence of a constitutive HS site at the IL10 promoter region in D10/ Th2 but not D5/ Th1 cells (Figure 2 ), taken together with the ability of D10/ Th2 but not D5/ Th1 cells to transcribe IL10 (5) , suggested that the promoter was poised for active transcription in Th2 cells but was silenced in committed Th1 cells. To test this hypothesis, we used the chromatin immunoprecipitation (ChIP) technique ( Figure 4A ). For technical reasons, only D5 and D10 clones, which constitute homogeneous, committed and strongly-transcribing cell populations, could be used in this assay. The cells were stimulated, fixed with formaldehyde to crosslink DNA-protein complexes, and sheared DNAs were immunoprecipitated using antibodies to RNA polymerase II, acetylated histone H4, and the inducible transcription factor NFAT1. PCR was performed to detect association of the IL10 promoter with the respective immunoprecipitated fraction; IL4 and IFNg promoter primers were used as controls. Like the IL4 promoter, the IL10 promoter was hyperacetylated on histone H4 in D10 Th2 cells even prior to stimulation ( Figure 4A , top two panels, row 3). Both promoters showed basal occupancy by RNA polymerase II (Pol II) (row 4), confirming their poised status. IL4 and IL10 promoters became accessible to NFAT1 after stimulation ( Figure 4A , top two panels, row 2), correlating with the rapid increase in IL-4 and IL-10 production by stimulated D10 cells. In contrast D5 T cells, which do not produce either IL-4 or IL-10, showed no histone hyperacetylation, Pol II occupancy or inducible NFAT1 binding at either of these two promoters ( Figure 4A , top two panels). However they showed constitutive hyperacetylation, constitutive Pol II occupancy and inducible NFAT1 binding at the IFNg promoter, consistent with their competence to produce IFN-g upon stimulation ( Figure 4A , bottom panel).
As a further test of differential promoter accessibility, we probed the methylation status of the IL10 promoter in D5 and D10 cells, using the methylation-sensitive and -insensitive enzyme pair Hpa II/ Msp I which recognize 5'-CCGG sites ( Figure 4B ). Bam HI digestion of D5 or D10 DNA yielded a 6 kb band that hybridised to the exon 1 probe ( Figure 4B, lanes 1, 3) , while digestion with Bam HI plus Msp I yielded the expected 1.2 and 0.7 kb fragments hybridising to the exon 1 probe (lanes 2, 4; see diagram at bottom). After Hpa II digestion of D5 DNA, the 6 kb fragment was partially converted to a slightly smaller fragment, with no appearance of an 0.7 kb fragment (lane 3), indicating partial demethylation of the intronic Hpa II site (c) but complete methylation of the Hpa II sites in the IL10 promoter (a) and in exon 1 (b) (see diagram). In contrast Bam HI-digested D10 DNA was fully cleaved by Hpa II, resulting in 1.2 kb and 0.7 kb fragments hybridizing to the IL10 exon 1 probe (lane 6) and showing full demethylation at all three Hpa II sites.
NFAT binding to an intronic region of the IL10 gene in the D5 Th1 clone
Given the degree of promoter inactivation in D5 cells, it was surprising that inducible HS sites appeared in intronic regions of the IL10 gene in Th1 cells stimulated with PMA and ionomycin (Figures 3, 4) . We examined whether histones at HS sites I and II bore two modifications generally associated with active genes, acetylation of histone H4 and dimethylation of histone 3 lysine 4 (H3K4m) (10, 11) . As expected from the silenced status of the IL10 gene in D5 cells, the levels of both histone modifications were considerably lower in D5 cells than in D10 cells ( Figure 5A , rows 1 and 2). Furthermore, the histone deacteylase HDAC1 was more strongly associated with HS sites I and II in D5 cells than in D10 cells (row 3), again consistent with IL10 gene silencing in D5 cells.
Since CsA blocked induction of all the inducible HS sites in D5 Th1 cells (Figures 3, 4) , we asked whether NFAT proteins participated in their formation. We searched for conserved NFAT binding sites in the IL10 promoter and intronic regions using the program rVISTA [(12,13) . version 2.0, http://rvista.dcode.org/). This analysis identified NFAT binding sites in the IL10 promoter, intron 3 and intron 4, which were strongly conserved between human and mouse ( Figure 5B and data not shown). ChIP assays showed that NFAT1 bound strongly and inducibly to the inducible HS site II, located in intron 4 of the IL10 gene in D5 but not D10 cells ( Figure 5A , row 4). In contrast, NFAT1 did not bind to HS site I located in intron 3, even though this intron contains a conserved NFAT binding site. The difference could reflect the different sequence contexts of the NFAT binding sites: the sites at the promoter and intron 4 do not contain an adjacent AP-1 binding site ( Figure  5B ) and NFAT binding may therefore be stabilised by a partner protein already present in the nucleus under the stimulation conditions used, whereas the site in intron 3 is a likely composite NFAT:AP-1 site in the mouse (data not shown), which would be predicted not to support NFAT binding at early times after stimulation when AP-1 proteins are not yet induced (14) .
DISCUSSION
We have defined the patterns of DNase I hypersensitivity in the IL10 locus of naïve and differentiating T cells. DNase I hypersensitive sites mark nucleosome-poor regions that tend to be located in the vicinity of protein-bound regulatory elements: they have been shown in different systems to function as enhancers, locus control regions, matrix attachment regions, or insulator/ boundary elements. DNase I hypersensitivity analysis is useful for at least two reasons: it provides a first indication of whether a gene is transcriptionally competent or silenced, and it constitutes a simple method for long-range mapping of potentially important regulatory regions of the gene.
Bioinformatic analysis of the IL10 gene shows a remarkable correspondence between the positions of experimentally-determined HS regions and conserved non-coding sequence (CNS) regions identified by sequence comparisons of mammalian genomes ( Figure 6 ). This correspondence appears to be a common feature of cytokine genes, since it has also been noted in the IL4/ IL13 7 and IFNg loci (6, (15) (16) (17) ; J Nardone, D Lee, M Ansel & A Rao, unpublished). All six HS sites identified in our analysis --HS sites I-V and the HS site at the IL10 promoter --map in the vicinity of CNS regions that are highly-conserved between human and mouse ( Figure 6 ; note that HS sites are generally found at the boundaries of protein-bound regulatory elements, not within the occupied regions themselves (18) . A longer-range view of the IL10 locus, shown in Figure 6B , indicates the presence of several other CNS regions in the vicinity of the IL10 gene. Further analysis is needed to determine which of these regions is pertinent to regulation of the IL10 gene and which to regulation of the flanking IL19 and MAPKAPK2 genes. A comprehensive analysis of DNase I hypersensitivity, performed in a large number of different IL-10-producing cell types at all possible developmental stages and under all possible conditions of stimulation, will be necessary to reveal all conserved regions which participate in IL10 regulation in any given cell type under specified conditions of stimulation.
The most striking hypersensitive site in the IL10 locus is constitutive HS site III, located immediately 3' of the last exon of the IL10 gene. This site is not apparent in naïve CD4 T cells, and develops in both Th1 and Th2 cells following TCR stimulation. The sequence of HS III is highly conserved (about 85%) in human, mouse and rats (data not shown) and corresponds to a CNS region as shown in Figure 6 . The characteristic properties of this site (absence from naïve T cells, constitutive rather than inducible hypersensitivity in differentiated T cells) suggest that it binds lineage-specific transcription factors, rather than inducible transcription factors that mediate acute transcription of the IL10 gene. Like GATA3 and T-bet in Th1 and Th2 cells respectively, such lineage-specific factor(s) responsible for IL10 gene expression may function to impose the remodelled chromatin structure of the IL10 locus and maintain it in a transcriptionally-competent state (6) .
Our studies focus attention on the IL10 promoter as a major region that determines IL10 expression in differentiated T cells. The promoter is the only identified region of the IL10 gene which assumes a fully inactive chromatin configuration in committed D5 Th1 cells, as judged by hypoacetylation at histone H4, CpG methylation at two Hpa II sites, and inaccessibility to binding of the inducible transcription factor NFAT1. The remainder of the IL10 locus remains accessible to binding of transcription factors, as judged by the appearance of intronic and 3' inducible hypersensitive sites, and the direct demonstration of NFAT1 binding to HS site II by ChIP. This behaviour is quite different from that previously documented for IL4, where Th1 cells that have shut off IL4 not only silence the IL4 promoter (Figure 4 ; (4), but show no HS sites other than those observed in naïve T cells (5) and do not develop the inducible HS site at the 3' IL4 enhancer following stimulation (19) . The promoter-directed silencing of the IL10 gene also contrasts with the behaviour of the IFNg gene, which when silenced in Th2 cells shows no hypersensitivity whatsoever (19) .
It is curious that binding of NFAT1 to several cytokine promoters (IL10, IL4, IFNg) correlates with an "open" configuration of chromatin, characterised for instance by increased levels of histone H4 acetylation prior to stimulation (4), whereas binding of the same transcription factor to intron 4 (HS site II) of the IL10 gene occurs despite a "silenced" chromatin configuration characterised by decreased histone H4 acetylation, decreased histone H3K4 dimethylation and constitutive association with the histone deacetylase HDAC1. Inducible binding of NFAT1 to a site in exon 1 of the cyclin-dependent kinase 4 (CDK4) gene was reported to repress CDK4 expression by recruiting HDAC1 (20) . HDAC recruitment by NFAT may also contribute to silencing of a subset of the large number of genes, identified by DNA array analyses, whose expression is decreased by calcium/ calcineurin signalling (21) . However in the IL10 gene, HDAC1 is constitutively associated with both IL10 introns in D5 cells while NFAT1 binds inducibly only to intron 4, suggesting that HDAC1 is recruited not by NFAT but rather by repressive factor(s) pre-bound to the intronic HS sites. The identity of these repressive factors awaits further analysis.
To summarise, our data emphasise the surprising diversity of mechanisms used to regulate gene expression at the chromatin level. We have defined for the first time the DNase I hypersensitivity patterns of the IL10 gene in naïve and differentiated T cells. This analysis has revealed that the majority of DNase I hypersensitive sites correspond to conserved non-coding genomic regions identified by sequence comparisons of mammalian genomes. Furthermore, the analysis shows that different cell types expressing the same gene choose different subsets of the conserved CNS regions as DNase I hypersensitive sites, implying that the evolutionary conservation of these regions derives not from their simultaneous participation in gene expression in all expressing cell types, but rather from their specialised roles as protein-binding regulatory elements in individual cell types. We have also described a novel silencing mechanism directed selectively to the promoter of the IL10 gene, which is not observed in other cytokine genes such as IL4 and IFNg.
Since this mechanism appears to maintain IL10 intronic regions in a state of reversible HDACmediated silencing even in fully-committed T cell clones, it may represent an evolutionary adaptation that permits reactivation of the IL10 gene under appropriate physiological or pathological conditions. EXPERIMENTAL PROCEDURES Mice DO11.10 mice (transgenic for an abTCR specific for the OVA 323-339 peptide) on a BALB/c background were maintained in pathogen-free conditions in barrier facilities at the Center for Animal Resources and Comparative Medicine, Harvard Medical School.
Cell lines and primary T cells
The murine D5 Th1 clone (Ar-5; (8) and D10 Th2 clone (D10.G4.1; (9) were maintained as described previously (5) . CD4 T cells were purified from DO11.10 mice and differentiated under Th1 and Th2 conditions for 1-2 weeks (4, 19) . Cells were left unstimulated or stimulated for the indicated times with 2 mM ionomycin alone, or 10 nM PMA plus 2 mM ionomycin in the presence or absence of 1 mM CsA.
Analysis of DNase I hypersensitivity and DNA methylation
Cells were stimulated for 4 h as described above, and nuclei were isolated and incubated with DNase I (22) . Purified genomic DNAs were completely digested with Bam HI and resolved on a 0.6% agarose gel, transferred to Nytran membranes, and hybridized with IL-10 exon 1, exon 3 or exon 5 probes labeled by random priming. For methylation analysis of Th1 (D5) and Th2 (D10) clones, genomic DNAs were prepared and digested completely with Bam HI. They were purified and further digested with methylation-sensitive (Hpa II, 100 U) or -insensitive (Msp I) enzymes. Digested samples were further processed for Southern analysis with indicated IL-10 exon probes.
Chromatin Immunoprecipitation (ChIP) Assays
ChIP analysis was carried out essentially as described (23) . Th1 (D5) or Th2 (D10) cells (10 8 ) were either left unstimulated or were stimulated for 20 min with PMA (10 nM) plus ionomycin (2 mM), then cross-linked using formaldehyde. This early time point was chosen based on the early kinetics of IL-10 gene transcription (peak transcript levels attained at 20 min in both the D10 Th2 clone and primary Th2 cells; FIGURE 2 and data not shown). Nuclei were isolated and sonicated four times for 10 s each at the maximal setting, with 1 min cooling on ice in between. The average size of sonicated DNA was about~0.5kb. The chromatin was Immunoprecipitated using anti-NFAT1 (anti-67.1 and anti-NFAT1-C antibodies specific for the family member NFAT1-C) (24), antiacetyl-histone H4 (Upstate Biotechnology, Lake Placid, NY), anti-Pol II (sc-899; Santa Cruz Biotechnology, Santa Cruz, CA) or rabbit IgG (Sigma). Following reversal of cross-links, the presence of selected DNA sequences was assessed by PCR.
The primers used in ChIP were as follows: IL-10 promoter, 5'-GAGTGCTAAGGTGACTTCCGA-3' and 5'-AACTTCTGCATTACAGCTATTTTT-3' (280 bp product); IL-4 promoter, 5'-TGATAAGATTAGTCTGAAAGGCCGATT-3' and 5'-GTTTATCAAGAGATGCTAACAATGCAATG-3' (300bp product); IFN-g promoter, 5'-CTGTGCTCTGTGGATGAGAAATTCACA-3' and 5'-TTTAAGATGGTGACAGATAGGTGGG-3' (257bp product).
As a loading control, the PCR was done directly on input DNA purified from chromatin before immunoprecipitation. PCR products were resolved on 1.5 % agarose gels.
Bioinformatics
Alignments between the mouse and human IL-10 loci were performed and the extent of DNA sequence homology was computed with a web-based program, VISTA (http://wwwgsd.lbl.gov/vista) (12, 13) . In Figure 6 , the plot of percent sequence identity is referred to the mouse sequence. Regions with a length of at least 100 bp, which show at least 75% sequence identity at each segment of the alignment between successive gaps, are identified as CNS regions and are shown in red. 100%   75%   50%   0k  1k  2k  3k  4k  5k  6k  7k  8k  9k  10k  11k  12k  13k  14k  15k  16k  17k  18k  19k  20k   IL19   100%   75%   50%   20k  21k  22k  23k  24k  25k  26k  27k  28k  29k  30k  31k  32k  33k  34k  35k  36k  37k  38k  39k  40k   IL10   100%   75%   50%   40k  41k  42k  43k  44k  45k  46k  47k  48k  49k  50k  51k  52k  53k  54k  55k  56k  57k  58k  59k  60k   100%   75%   50%   60k  61k  62k  63k  64k  65k  66k  67k  68k 
